https://www.selleckchem.com/products/cd437.html
There is a paucity of data on blood loss and the risk of allogeneic blood transfusion after simultaneous bilateral total hip arthroplasty (SBTHA) with contemporary blood management including neuraxial anesthesia, routine tranexamic acid use, and a restrictive transfusion protocol. As such, we sought to determine the in-hospital outcomes of SBTHA, specifically analyzing blood loss and the rate and risk factors for transfusion. We identified 191 patients who underwent SBTHA at a single institution from 2016 to 2019. No drains were utilized
Like
Comment
Share
